A primer on recent developments in cancer immunotherapy, with a focus on neoantigen vaccines

  • Tokuyasu T
  • Huang J
N/ACitations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Cancer immunotherapy has now been conclusively shown to be capable of producing durable responses for a substantial number of patients. Adoptive cell transfer and checkpoint blockade therapies in particular both demonstrate that antigen-specific immune responses can be dramatically effective, even in previously refractory late stage disease. Such developments, together with advances in technology, have strongly encouraged revisiting the concept of neoantigen vaccines. Here we introduce basic ideas in the field to allow investigators from diverse backgrounds to understand these developments, grasp current issues, and contribute to further progress.

Cite

CITATION STYLE

APA

Tokuyasu, T. A., & Huang, J.-D. (2018). A primer on recent developments in cancer immunotherapy, with a focus on neoantigen vaccines. Journal of Cancer Metastasis and Treatment, 4(1), 2. https://doi.org/10.20517/2394-4722.2017.52

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free